Skip to content

New targeted alpha- and beta emitter
treatments for metastatic cancer

Home
Team
Privacy

Author: objectl1

Hello world!

objectl1

February 26, 2024

Uncategorized

Welcome to WordPress. This is your first post. Edit or delete it, then start writing! Read more

NucliThera a.s

Kjelsåsveien 168B
NO-0884 Oslo
Norway

Enterprise number:
832 728 462 MVA

Management

Ludvik Sandnes CEO, CFO
Øyvind S. Bruland CMO
Roy Hartvig Larsen CTO
Ada Repetto-Llamazares CSO
Phone: +47 907 43 017
Email: post@nuclithera.com

Board of directors

Roy Hartvig Larsen, PhD
Ludvik Sandnes
Morten Lande, cand.scient.

Øyvind Bruland, Prof emerit, MD, PhD (deputy member)

Founders

Roy H Larsen
(Sciencons a.s, 80%)
Øyvind S. Bruland
(Blaahaugen a.s, 4%)
Morten Lande
(Syntax a.s, 16%)